Cargando…
Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report
We report improved lung function and quality of life following daily use of guaifenesin/dextromethorphan (Mucinex DM(®), Reckitt Benckiser) for the treatment of mucus-related symptoms in a patient with COPD, who presented with increasing dyspnea, progressive cough and chest congestion.
Autores principales: | Storms, William W., Miller, Judi E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010616/ https://www.ncbi.nlm.nih.gov/pubmed/29977767 http://dx.doi.org/10.1016/j.rmcr.2018.04.009 |
Ejemplares similares
-
Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report
por: Singer, Ethan, et al.
Publicado: (2018) -
Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report
por: Storms, William W., et al.
Publicado: (2018) -
Improved quality of life associated with long-term daily use of guaifenesin (Mucinex(®)) in a patient with chronic rhinosinusitis: a case report
por: Singer, Ethan, et al.
Publicado: (2018) -
Bilateral nephrolithiasis following ingestion of guaifenesin and dextromethorphan
por: Kim, Elizabeth, et al.
Publicado: (2023) -
Successful long-term, adjunctive use of guaifenesin in a patient with a complex atopic medical history and primary immune deficiency: A case report
por: Lanier, Bobby Quentin, et al.
Publicado: (2018)